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The Effect of High and Low Antiepileptic Drug Dosage on Simulated Driving
Performance in Person’s with Seizures: A Pilot Study
Abstract
Background: Prior studies examining driving performance have not examined the effects of antiepileptic
drugs (AED’s) or their dosages in persons with epilepsy. AED’s are the primary form of treatment to
control seizures, but they are shown to affect cognition, attention, and vision, all which may impair driving.
The purpose of this study was to describe the characteristics of high and low AED dosages on simulated
driving performance in persons with seizures.
Method: Patients (N = 11; mean age 42.1 ± 6.3; 55% female; 100% Caucasian) were recruited from the
Epilepsy Monitoring Unit and had their driving assessed on a simulator.
Results: No differences emerged in total or specific types of driving errors between high and low AED
dosages. However, high AED drug dosage was significantly associated with errors of lane maintenance (r
= .67, p < .05) and gap acceptance (r = .66, p < .05). The findings suggest that higher AED dosages may
adversely affect driving performance, irrespective of having a diagnosis of epilepsy, conversion disorder,
or other medical conditions.
Conclusion: Future studies with larger samples are required to examine whether AED dosage or seizure
focus alone can impair driving performance in persons with and without seizures.
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When occupational therapists are

commonly used AED, causes confusion, dizziness,

determining an individual’s fitness to drive, they do

fatigue, and decreased concentration in patients

so primarily by conducting comprehensive driving

with seizures (Shorvon, 1996). Another AED,

evaluations, which typically consist of off- and on-

zonisamide, produces other cognitive deficits, such

road assessments. In many cases, drivers whose

as impairment of communication skills and recall of

fitness to drive has been questioned are referred by

visual-graphic task stimuli, and may cause

physicians or are flagged by the regulatory licensing

sleepiness in patients with partial seizures (Berent et

board. However, with some medical conditions,

al., 1987). Because cognitive and visual processing

such as epilepsy, there is a paucity of literature

skills are important to driving, AEDs may also

concerning how the symptoms or side effects of

adversely impact driving performance.

antiepileptic drugs can impair driving performance.

In a double-blind randomized crossover

Current guidelines do not provide strong directions

study in 27 healthy drivers without neurological

for occupational therapists, who, ultimately, are

conditions, simulated driving performance was

responsible for determining how the symptoms and

compared at baseline (no meds) and after dosages of

medications related to epilepsy can impact an

either carbamazepine (CBZ) or oxcarbamazepine

individual’s driving ability (National Institute of

(OXC) were administered and progressively

Neurological Disorders and Stroke, n.d.).

increased (Kaussner et al., 2010). The participants

Epilepsy, characterized by recurrent seizures

made significantly more lane maintenance errors

resulting in altered neurological function (Tippin,

and more total driving errors when taking both

Sparks, & Rizzo, 2009), can pose a risk to road

AEDs. When comparing the two drugs, the

safety (Classen, Crizzle, Winter, Silver, &

participants taking CBZ made significantly more

Eisenschenk, 2012; Sheth, Krauss, Krumholz, & Li,

total driving errors than when taking OXC,

2004) due to impairments of motor, visual, and

indicating that CBZ may have more adverse side

cognitive skills (Drazkowski, 2007). One way to

effects on driving (Kaussner et al., 2010).

control seizures is through the use of antiepileptic

Comparatively, another study examined the effects

drugs (AEDs). While AEDs result in seizure

of AED dosages on driving performance in healthy

remission in approximately two-thirds of people

drivers without neurological conditions on a road

with epilepsy (World Health Organization, 2005),

test (Ramaekers et al., 2002). The participants were

the side effects of some of these medications may

randomized into three groups (600 mg of CBZ vs.

impair multiple domains of cognition, such as

600 mg of remacemide vs. a placebo), and it was

memory and attention (Meador et al., 1995), and

found that CBZ resulted in worse driving

may cause blurred vision and/or fatigue

performance based on deviations of standard lane

(Drazkowski, 2007). For example, topiramate, a

positioning compared to remacemide and the
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placebo. However, neither of these studies included

driving performance (number and type of errors) in

persons with epilepsy or seizures. The underlying

persons with seizures on their high vs. low AED

impairment of seizures may also cause cognitive,

dosages. The primary aim of this study was

motor, or visual impairment potentially leading to

twofold: (a) to identify simulated driving errors

difficulties with driving further exacerbated by

(e.g., lane maintenance, adjustment to stimuli, speed

AED therapy.

regulation, gap acceptance, signaling, visual

While the criterion measure for assessing

scanning, and vehicle position) made during high

driving performance is an on-road evaluation (Kay,

and low AED dosage in persons with seizures; and

Bundy, Clemson, & Jolly, 2008), the risk of

(b) to determine if correlations existed between high

seizures while driving places the driver, evaluator,

and low AED dosage with specific and total number

passengers, and other road users at risk. Although

of simulated driving errors in persons with seizures.

questions still remain on the utility of simulators in

Method

clinical practice for determining fitness to drive,
research studies can use simulators to test driving

Participants
The Institutional Review Board at the

performance in a safe, objective, and accurate

University of Florida (UF) granted ethics approval,

manner (de Winter et al., 2009). Research studies

and each participant provided informed consent

using simulators have found evidence of relative

prior to participation. Persons with epilepsy or

and absolute validity compared to on-road testing

seizures were referred to the UF in-patient Epilepsy

(Shechtman, Classen, Awadzi, & Mann, 2009).

Monitoring Unit (EMU) if they had refractory

Only one study has prospectively examined

epilepsy, increased seizure frequency despite using

simulated driving performance in people with

AEDs, or had new variations of seizure activity

epilepsy and found associations between clinical

(e.g., simple partial to complex partial) not

tests and driving errors (i.e., visual scanning,

exhibited previously. The participants, referred by

adjustment to stimuli, lane maintenance, vehicle

fellowship-trained epileptologists from the EMU,

position, and total errors), but that study did not

were eligible if: (a) they were 18 years or older, (b)

examine specific AEDs or their dosages on driving

showed evidence of paroxysmal events with loss of

performance (Crizzle et al., 2012). Given that

consciousness, (c) had a valid driver’s license or an

improving evidence-based practice is at the

intent to obtain one, (d) were community dwelling,

forefront of research agendas in occupational

and (e) had the physical and mental capacity to

therapy, identifying features of medical conditions

complete the study as determined by the

and associated medications that can impair driving

epileptologist. Exclusion criteria consisted of: (a)

is of paramount importance. Thus, the objective of

severe psychiatric (e.g., psychosis) and physical

the present study was to describe the simulated

conditions (e.g., missing limbs), (b) multiple
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psychotropic medications that negatively affect

of the participants during the low and high AED

physical and cognitive function, and (c) pregnant

dosage drives are shown in Table 1. Low-dose

females. Two individuals were screened out due to

AED was determined if the patient was taking <

meeting the exclusion criteria.

50% of the original AED doses at more than three

Design

half-lives for the specific AED prior to testing. “No
This quasi-experimental study employed a

medications” was designated if AED(s) had been

single group design to determine the effects of AED

discontinued for more than three half-lives prior to

dosages on driving performance using a simulator.

testing. The participants completed questionnaires

Participants in a single group were compared on

on demographics, driving habits, and history,

their simulated driving performance while taking

followed by driving on a high-fidelity DriveSafety

low and high dosages of AEDs. As persons with

DS-250r™ simulator, which is fully maneuverable

epilepsy can have residual cognitive deficits from

on the EMU.

repeated seizures, a control group was not included
as part of this study (as healthy adults are unlikely
to have cognitive deficits).
Procedure
The participants were admitted to the EMU
and monitored continuously (typically over 5 days)
via electroencephalogram. To elicit seizures, AED
dosages were reduced or withdrawn under medical

Table 1
Medication Type and Dosage Taken During High
vs. Low AED Drives
Participants

Medication at
high dosage

Medication at
low dosage

#1

Lacosamide 200 mg

Lacosamide 100mg

#2

Zonisamide 100mg;
Lacosamide 50mg

No medications

#3

Lamotrigine 150mg;
Levetiracetam
1000mg;
Clonazepam 0.50mg
Lamotrigine XR
100mg;
Oxcarbazepine
750mg
Zonisamide 50mg

Lamotrigine 50mg

Phenytoin 400 mg;
Topiramate 200mg
Zonisamide 300mg

Topiramate 50mg

Levetiracetam
1500mg
Topiramate 50mg

No medications

Levetiracetam
1000mg
Valproate 1500mg

No medications

supervision. The participants were tested on the
simulator twice: first under their usual medication

#4

dosage (prescribed dosage) and then after having
their AED’s reduced or withdrawn to elicit seizure
activity. To control for practice effects, six of the

#5
#6

participants completed their first drive on their
lowest AED dosage, followed by a second drive on

#7
#8

their usual medications. Alternatively, five
participants completed their first drive on their
usual medications followed by a second drive on

#9
#10
#11

Lamotrigine XR
50mg

No medications

No medications

No medications

No medications

their lowest AED dosage. The participants’ exact
AED dosages were obtained from medical records
provided by the epileptologist. Medications for all

Published by ScholarWorks at WMU, 2015
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Driving Simulator and Scenarios
The simulator design is based on a one-

lasting approximately 5 min each. After the
participants felt comfortable driving on the

fourth cab of an automatic transmission Ford Focus

simulator, they drove a 35-min scenario while on

with a single adjustable seat and 5-point safety

low and high AED dosages (or vice versa), usually

harness (see Figure 1). To optimize driving close to

a few days apart. A 35-min simulator drive has

the real world experience, the simulator was

been employed in prior studies examining the

equipped with vehicle components (e.g., brake and

influence of drugs (Brown, Milavetz, & Murry,

gas pedal, air conditioning, turn signals). The

2013), epilepsy (Crizzle et al., 2012), and

simulator has a high-resolution display (1024 x 748

obstructive sleep apnea (Vakulin et al., 2011). The

pixels) and provides the participants with a 110-

scenario was created to portray daylight and

inch horizontal view across three screens (each

included ambient traffic but no turns. The drive

screen is 19 inches). The participants were required

started in a rural setting, progressed to a commercial

to adjust the seat and fasten the safety belt, and to

area, a freeway, and then to a residential area, with

control the steering wheel and gas and brake pedals.

speed limits appropriately varying from 25-65 miles
per hour. The participants were instructed to
identify all yellow road signs, exit signs, and
billboards. A clinical researcher, trained by a
certified driving rehabilitation specialist with 98%
of inter-rater reliability in test administration,
evaluated the participants’ driving performance and
recorded driving errors. The Simulator Sickness
Questionnaire (SSQ) (Kennedy, Lane, Berbaum, &
Lilienthal, 1993) was administered to screen for
simulator sickness symptoms before and after the
participants completed three acclimation scenarios
(curvy roads, stopping, and lane control) and after

Figure 1. Portable DriveSafety DS-250 r™ simulator
with a 5-point restraint

the main drive.
The driving errors the researcher recorded
were: visual scanning, lane maintenance, speed

To optimize comfort and confidence in

regulation, vehicle position, adjustment to stimuli,

driving the simulator, the participants completed

signaling, gap acceptance, and yielding (Shechtman

three acclimation scenarios (driving in the middle of

et al., 2009). As detailed in a prior study (Crizzle et

the lane, driving around curves, and stopping)

al., 2012), the drive also included three scripted

https://scholarworks.wmich.edu/ojot/vol3/iss4/3
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events that required the driver to avoid collisions:

admission to the EMU, seven were diagnosed with

one at a train crossing and two where a car enters

epilepsy and four with conversion disorders (non-

the driving lane from a parked position. All of the

epileptic seizures). We did not segregate by

participants had equal opportunities to make these

epilepsy and convergent disorders as there were no

errors over the two simulated drives.

differences in driving performance between the

Data Analysis

groups (z = -.878, p = .38) and the patients in both

All data was entered into SPSS (version
20.0) for analyses. The researchers used descriptive
statistics (mean, standard deviation, and range) to

groups were taking AEDs.
Self-Reported Driving Habits and History
The participants reported driving 2.9 ± 3.4

analyze continuous variables (i.e., number of

days per week. Six of the 11 participants had quit

driving errors) and frequencies (percent) to analyze

driving prior to EMU admission. Two of the

categorical variables. The researchers also used

participants reported having been in a crash in the

Spearman’s rank correlations to examine the

past three years, both current drivers. Four of the

associations between low and high AED dosages

participants reported receiving citations in the past

with the numbers of driving errors (total and type).

three years—three of which reported speeding

Statistical significance was considered for alpha ≤.

infractions (two former and one current driver) and

05 in a two-tailed test.

one an improper turning citation (current driver).
Results

Participants
Twenty-two participants enrolled in the
study; however, only 11 were able to complete the
entire protocol. Reasons for study incompletion

Twenty-seven percent (n = 3) of the sample
reportedly avoided driving in the rain, during rush
hour, on the highway, or at nighttime.
Simulated Driving Performance
Descriptive statistics for type and total

included fatigue over the course of the hospital stay

number of driving errors during high and low AED

(e.g., being busy with family visitations) and the

dosages are provided in Table 2. The most

development of simulator sickness. The sample (six

frequently committed driving errors in both low and

women; five men) ranged from 32 to 51 years of

high AED dosage drives included errors of speed

age (mean age of 42.1 ± 6.3), had an average high

regulation and lane maintenance. Generally, the

school education (12.6 years ± 3.0), and was all

participants made more total driving errors, as well

Caucasian. Eighty-two percent (n = 9) lived with

as errors of visual scanning and speed regulations,

their spouse or partner while two lived alone. After

while on their high compared to low AED dosage.

Published by ScholarWorks at WMU, 2015
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Table 2
Descriptive Statistics for Driving Errors between High and Low AED Drives
High Dosage
Low Dosage
Driving Errors
M ± SD Range
M ± SD Range
Visual Scanning
3.8 ± 3.2 [0-10]
2.8 ± 3.3 [0-10]
Speed Regulation
5.7 ± 5.5 [0-15]
5.0 ± 4.4 [0-13]
Lane Maintenance
5.8 ± 4.1 [0-13]
6.1 ± 5.2 [1-18]
Wide
2.5 ± 3.8 [0-13]
2.4 ± 5.3 [0-18]
Encroach
3.4 ± 3.0 [0-8]
3.6 ± 3.1 [0-9]
Signaling
.45 ± .69 [0-2]
.55 ± .82 [0-2]
Vehicle Position
1.8 ± 2.2 [0-7]
1.7 ± 1.6 [0-4]
Adjustment to Stimuli
.82 ± .98 [0-2]
.45 ± .69 [0-2]
Gap Acceptance
36 ± .50 [0-1]
.18 ± .60 [0-2]
Total Errors
19.0 ± 9.9 [6-43]
17.1 ± 8.9 [5-28]
Note. M = mean, SD = standard deviation
As shown in Table 3, high AED dosages
were significantly associated with errors of lane

between driving errors and low AED dosage were
significant.

maintenance and gap acceptance. No associations
Table 3
Spearman’s Correlation Coefficient of Errors on High and Low Dosage AED Drives
High Dosage
Low Dosage
Driving Errors
r
p
r
p
Visual Scanning
.05
.88
.07
.84
Speed Regulation
.05
.88
.30
.37
Lane Maintenance
.49
.13
-.33
.33
.03*
-.44
.18
Wide
.67
Encroach
.01
.97
.01
.98
Signaling
.15
.66
.32
.33
.27
.38
.26
Vehicle Position
.36
Adjustment to Stimuli
.51
.11
.48
.13
Gap Acceptance
.66
.03*
.00
1.0
Total Errors
.44
.18
.09
.78
Note. r = correlation coefficient, * denotes significance on a 2-tailed test, p < .05

Discussion
The findings suggest that occupational

compared to low AED dosages. Consistent with a
prior study (Crizzle et al., 2012), the most

therapists need to consider the effects of AEDs

commonly committed errors in the present study

when assessing fitness to drive in persons with

were speed regulation and lane maintenance errors.

seizures. Generally, the participants made more

Although individuals taking AED’s may have more

simulated driving errors while on their high

difficulties with speed regulation and lane

https://scholarworks.wmich.edu/ojot/vol3/iss4/3
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maintenance, the findings suggest that driving may

compared to both OXC (Kaussner et al., 2010) and

be affected for anyone taking AEDs for any reason,

remacemide (Ramaekers et al., 2002).

including pain, migraines, and mood disorders,

Limitations

consistent with prior findings (Kaussner et al.,

The primary limitation of the present study

2010; Ramaekers et al., 2002). This has

was the small sample size (potential for type II

implications not only for persons with seizures but

error). However, our sample acted as their own

also for patients with other medical conditions who

controls, and we did ensure practice effects were

use AEDs.

not confounded by drug dosage. Although we

We found that high AED dosages in our

recruited 22 participants for over two years, only 11

sample were significantly associated with errors of

participants met the criteria of driving under both

lane maintenance (driving wide) and gap

high and low AED dosages while at the EMU. Due

acceptance. As AEDs impair aspects of cognition,

to the loss of participants over the study protocol,

namely attention (Drazkowski, 2007), information

our power to determine statistically meaningful

processing speed (Wesnes, Edgar, Dean, & Wroe,

inferences concerning the effects of different AED

2009), and concentration (Shorvon, 1996), it is

dosages on simulated driving performance was

possible that our sample had more difficulty with

substantially reduced. Even though we obtained

proper lane maintenance and gap acceptance when

medication profiles from the participants’ medical

taking high AED dosages. As seven of the 11

records, without monitoring AED serum levels

patients were actually unmedicated in the low

(e.g., blood tests), we did not determine the actual

dosage condition, it is also possible that there may

AED dosage in their system at the time of the

have been a deterioration of simulator performance,

driving assessment. As a result, we could not

which perhaps may have inflated the error measure

determine if patients were in a steady state or

in the low dosage condition overall. Different AED

whether some tolerance had developed, although we

classes may have variable effects on the central

attempted to assess patients on the simulator

nervous system, and given that the group was

immediately after AEDs were administered at the

administered the same drug treatment, it is difficult

EMU.

to draw any conclusions regarding a specific AED

Implications for Further Research

on simulated driving performance. It is possible

Future prospective studies with larger

that certain AEDs may impair driving performance

homogenous samples are needed to discern the

more so than others. For example, prior studies

effects of specific AEDs and their respective

have found that on-road and simulated driving

dosages on driving performance in persons with

performance was worse when taking CBZ when

seizures. Additionally, there is a need to determine
if the underlying epileptic focus has an impact on

Published by ScholarWorks at WMU, 2015
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driving performance regardless of AED dosing.

function and driving ability measures. Future

While there were no differences between those with

studies should further assess those with seizures and

seizure and conversion disorders, there are

conversion disorders to determine if there are any

important features that should be considered in

effects of AEDs on driving performance.

future research. For example, epileptic seizures

Additionally, future studies should also use AED

affect the brain not only when they occur but in the

serum levels to ascertain the effects of AED

interictal period as well. Thus, any increase in their

concentrations on driving performance.

frequency (following lowering of drug dosages)

Understanding the effects of AEDs on driving

could alter driving ability. Conversely, as non-

performance will enhance decision-making when

epileptic seizures do not affect brain function,

prescribing AEDs, as well as occupational therapy

lowering of epileptic drugs in the non-epileptic

practice with respect to driver assessment.

group could lead to an improvement of brain

https://scholarworks.wmich.edu/ojot/vol3/iss4/3
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